Factors Affecting the Statural Growth Retardation in Children using Steroids in Idiopathic Nephrotic Syndrome
Asian Journal of Pediatric Research,
Background and Aim: Idiopathic nephrotic syndrome or nephrosis causes massive protein leakage in the urine. Its treatment requires steroids (prednisone, methylprednisolone), often for a prolonged period, notably in case of steroid-dependence or steroid-resistance. In children, long-term use of steroids can lead to several side effects such as statural growth retardation/ stunting. This study evaluated the frequency of stunting in idiopathic nephrotic syndrome in children on steroids and identified the associated factors.
Material and Methods: This was a retrospective, descriptive cohort study carried out in children aged 0 to 16 years treated at the paediatric nephrology unit of Aristide Le Dantec Hospital in Dakar, between 1 December 2017 and 31 May 2020. All records of nephrotic children treated in outpatient or inpatient setting were included. These children had to be on corticosteroid therapy for at least 30 months and have a height taken regularly during follow-up consultations.
Results: Of 259 children followed for idiopathic nephrotic syndrome, 93 were included in the study. The median age was 96.5 months and the sex ratio was 1.9. The mean height of the children at the beginning of the follow-up was -0.26 DS, at the end it was -0.88 DS. At the beginning of the follow-up, 8 children had already stunting. At 12 months follow-up, 72 children (77.4%) had a decrease in z-score; and at 30 months, there were 7 more children (84.9%) who had a decrease in z-score. Methylprednisolone boluses were given to 17 children (18.3%). Calcium supplementation was done in 91 children (97.8%). Vitamin D supplementation was given to 91 children (97.8%). The mean number of relapses was 1.8. Factors associated with stunting were number of relapses ≤3 (p=0.03), duration of corticosteroid therapy >6 months (p<0.0001) and cumulative doses of prednisone >100 mg/kg (p=0.04).
Conclusion: In prolonged nephrotic syndrome in children, corticosteroids can cause stunting.
- Nephrotic syndrome
How to Cite
Protocole National de diagnostic et de soins : syndrome néphrotique idiopathique de l’enfant. Centre de Référence Syndrome Néphrotique Idiopathique. 2016;30:32-42.
Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW. The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol. 2014;29:1159-1167.
Elder GJ. Nephrotic syndrome: don’t forget the bones !. Nephrology (Carlton, Vic.). 2008;13(1):43-44.
Bérard E, Broyer M, Dehennault M, Dumas R, Eckart P, Fischbach M, et al. Corticosensitive nephrotic syndrome (or nephrosis) in children: Therapeutic protocol proposed by the Société de Néphrologie Pédiatrique. Nephrol Ther. 2005;1(3):150-156.
Noone DG, Lijima K, Parekh R. Idiopathic nephrotic syndrome in children. The Lancet. 2018;392(10141):61-74.
Bacchetta J, Harambat J, Cochat P. Long term steroid therapy in children: Is adjunct therapy recevant in nephrotic syndrome. Arch Pediatr. 2008;15:1685-1692.
Hochberg Z. Mechanism of steroid impairment of growth. Horm Res. 2002;58(1):33-38.
Cochat P. Corticothérapie. In: P. Cochat, E. Berard. Néphrologie pédiatrique, Progrès en pédiatrie. Paris: Doin. 2011. P. 85-89.
Deschênes G, Vivarelli M, Peruzzi L. Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries. Eur J Pediatr. 2017;176:647-654.
Emma F, Sesto A, Rizzoni G. Long-term linear growth of children with severe steroid responsive nephrotic syndrome. Pediatr Nephrol. 2003;18:783-788.
Madani A, Umar SU, Taghaodi R, Hajizadeh N, Rabbani A, Mehrjardi HZ. The effect of long-term steroid therapy on linear growth of nephrotic children. Iran J Pediatr. 2011;21(1):21-27.
Donatti TL, Koch VH, Fujimura MD, Okay Y. Growth in steroid-responsive nephrotic syndrome : a study of 85 pediatric patients. Pediatr Nephrol. 2003 ; 18 : 789 - 95.
Kéita Y, Lemrabott AT, Sylla A, Niang B, KA EHF, Dial CM, et al. Le syndrome néphrotique idiopathique de l’enfant à Dakar : à propos de 40 cas. Pan Afr Med J. 2017;26:161-167.
Ndongo AA, Sylla A, Fall AL, Kéita Y. Le syndrome néphrotique de l’enfant au centre hospitalier universitaire de Dakar. Arch Pediatr. 2016;23(6):653-654.
WHO Multicentre Growth Reference Study Group, & de Onis M. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatrica. 2006;95: 76-85.
Society GHR. Consensus Guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence. J Clin Endocrinol Metab. 2000;85(11):3990-3993.
Donatti TL, Koch VHK, Takayama L, Pereira RMR. Effects of glucocorticoids on growth and bone mineralization. J Pediatr. 2011;87:4-12.
Rousseau-Nepton I, Lang B, Rodd C. Longterm bone health in glucocorticoid-treated children with rheumatic diseases. Curr Rheumatol Rep. 2013;15(3):315-322.
Coulibaly P, Koffy LA, Diarrassouba G, Konan MT. Growth in steroid-responsive nephrotic syndrome in Cote d’Ivoire. Nephrol Ther. 2015;11(3):160-163.
Garin EH, Grant MB, Silverstein JH. Insulinlike growth factors in patients with active nephrotic syndrome. Am J Dis Child. 1989;143(7):865-867.
Valavi E, Aminzadeh M, Amouri P, Rezazadeh A, Beladi-Mousavi M. Effect of prednisolone on linear growth in children with nephrotic syndrome. J Pediatr. 2020;96:117-124.
Hung YT, Yang LY. Follow-up of linear growth of body height in children with nephrotic syndrome. J Microbiol Immunol Infect. 2006;39(5):422-425.
Pereira RMR, Carvalho JF, Paula AP, Zerbini C, Domiciano DS, Gonçalves H, et al. Guidelines for the prevention and treatment of glucocorticoid induced osteoporosis. Rev Bras Reum. 2012;52:580-593.
Olney RC. Mechanisms of impaired growth: effect of steroids on bone and cartilage. Horm Res. 2009;72(1):30-35.
Motoyama O, Iitaka K. Final height in children with steroid‐sensitive nephrotic syndrome. Pediatr Int. 2007;49(5):623- 625.
Simmonds J, Grundy N, Trompeter R, Tullus K. Long-term steroid treatment and growth : a study in steroid-dependent nephrotic syndrome. Arch Dis Child. 2010;95(2):146-149.
Abstract View: 46 times
PDF Download: 24 times